Wednesday November 25 2009 | Biotechnology feed | All feeds

«Malignant Carcinoid Syndrome

Below is an extended Malignant Carcinoid Syndrome patents listing. Click here to return to the Malignant Carcinoid Syndrome main in depth entry.

Patents :
US Patent No.	Title
5804380	Telomerase activity assays
6365362	Methods and reagents for the rapid and efficient isolation of circulating cancer cells
6368789	Screening methods to identify inhibitors of telomerase activity
6391554	Detecting cancerous conditions by assaying for telomerase activity
6475789	Human telomerase catalytic subunit: diagnostic and therapeutic methods
6506559	Genetic inhibition by double-stranded RNA
6534538	Method for slowing heart valve degeneration
6551774	Diagnostic methods for conditions associated with elevated cellular levels of telomerase activity
6610839	Promoter for telomerase reverse transcriptase
6617110	Cells immortalized with telomerase reverse transcriptase for use in drug screening
6645731	Methods and reagents for the rapid and efficient isolation of circulating cancer cells
6342217	Radiation enhanced gene therapy for tumors expressing a gene for a viral pyrimidine kinase in the presence of a 5'-halogenated pyrimidine
6194206	Use of oligonucleotide telomerase inhibitors to reduce telomere length
6166178	Telomerase catalytic subunit
5830431	Radiolabeled peptide compositions for site-specific targeting
5830644	Method for screening for agents which increase telomerase activity in a cell
5837453	Telomerase activity assays
5840495	Methods for diagnosis of conditions associated with elevated levels of telomerase activity
5863726	Telomerase activity assays
5869035	Methods and compositions for inducing complement destruction of tissue
5891639	Telomerase activity assays
5985266	Radiation enhanced therapy for tumors expressing a gene for viral thymidine kinase in the presence of a 5-halogengated pyrimidine
5989807	Detecting cancerous conditions by assaying for telomerase activity
6007989	Methods of screening for compounds that derepress or increase telomerase activity
6660260	Bioprosthetic heart valves
6881542	Serine threonine kinase member, h2520-59
7413864	Treating cancer using a telomerase vaccine
7442778	Modified Fc molecules
7449555	Antibodies of angiogenesis inhibiting domains CD148
7473528	Method for the detection of Chagas disease related gene transcripts in blood
7494979	Method for treating congestive heart failure and other disorders
7517971	Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity
7521053	Angiopoietin-2 specific binding agents
7538095	Genetic inhibition by double-stranded RNA
7560437	Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase
7560438	Genetic inhibition by double-stranded RNA
7371727	Methods and compositions for the treatment of gastrointestinal disorders
7332288	Methods and reagents for the rapid and efficient isolation of circulating cancer cells
7304036	Methods and compositions for the treatment of gastrointestinal disorders
6893867	Molecular switch for regulating mammalian gene expression
7029892	Serine threonine kinase member, h2520-59
7041786	Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
7078491	Selective binding agents of telomerase
7138370	Specific binding agents of human angiopoietin-2
7195911	Mammalian cells that have increased proliferative capacity
7199234	Regulatory segments of the human gene for telomerase reverse transcriptase
7205275	Methods of treatment using specific binding agents of human angiopoietin-2
7232805	Cobalamin conjugates for anti-tumor therapy
7262288	Nucleic acids encoding human telomerase reverse transcriptase and related homologs
7585622	Increasing the proliferative capacity of cells using telomerase reverse transcriptase

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

«Malignant Carcinoid Syndrome

Below is an extended Malignant Carcinoid Syndrome patents listing. Click here to return to the Malignant Carcinoid Syndrome main in depth entry.

Patents :